Evidence map›Paper›PMID 39066872›Full record

ArticleNeurogenetics2024

A novel missense variant in the ATPase domain of ATP8A2 and review of phenotypic variability of ATP8A2-related disorders caused by missense changes.

Kyle P Flannery, Sylvia Safwat, Eli Matsell, Namarata Battula, Ahlam A A Hamed, Inaam N Mohamed, Maha A Elseed, Mahmoud Koko, Rayan Abubaker, Fatima Abozar and 6 more

Abstract readCase Reports
In one paragraph

Article in Neurogenetics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Early-Onset Hyperkinetic Movement Disorders Define the Most Severe Presentation of the ATP8A2-Related Phenotypic Spectrum.International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience · 2026
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Kyle P Flannery *Department of Neuroscience & Cell Biology, Rutgers-Robert Wood Johnson Medical School, New Brunswick, NJ, 08901, USA.
Sylvia Safwat *Department of Neuroscience & Cell Biology, Rutgers-Robert Wood Johnson Medical School, New Brunswick, NJ, 08901, USA.
Eli MatsellDepartment of Biochemistry & Molecular Biology, University of British Columbia, Vancouver, B.C, Canada.
Namarata BattulaDepartment of Neuroscience & Cell Biology, Rutgers-Robert Wood Johnson Medical School, New Brunswick, NJ, 08901, USA.
Ahlam A A HamedFaculty of Medicine, University of Khartoum, Khartoum, Sudan.
Inaam N MohamedFaculty of Medicine, University of Khartoum, Khartoum, Sudan.
Maha A ElseedFaculty of Medicine, University of Khartoum, Khartoum, Sudan.
Mahmoud KokoInstitute of Endemic Diseases, University of Khartoum, Khartoum, Sudan.
Rayan AbubakerSudanese Neurogenetics Research group, Faculty of Medicine, University of Khartoum, Khartoum, Sudan.
Fatima AbozarFaculty of Medicine, University of Khartoum, Khartoum, Sudan.
Liena E O ElsayedDepartment of Basic Sciences, College of Medicine, Princess Nourah bint Abdulrahman University, P.O.Box 84428, Riyadh, Riyadh, 11671, Saudi Arabia.
Vikram BhiseDepartment of Pediatrics and Neurology, Rutgers - Robert Wood Johnson Medical School, New Brunswick, NJ, USA.
Robert S MoldayDepartment of Biochemistry & Molecular Biology, University of British Columbia, Vancouver, B.C, Canada.
Mustafa A SalihConsultant Pediatric Neurologist, Health Sector, King Abdulaziz City for Science and Technology, Riyadh, 11442, Saudi Arabia.
Ashraf YahiaDepartment of Biochemistry, Faculty of Medicine, University of Khartoum, Khartoum, Sudan.
M Chiara ManziniDepartment of Neuroscience & Cell Biology, Rutgers-Robert Wood Johnson Medical School, New Brunswick, NJ, 08901, USA. chiara.manzini@rutgers.edu.

Funding

Identification of Genetic and Molecular Pathways in Congenital Rare Disorders Affecting the Brain and MuscleR01NS109149 · NINDS · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI MANZINI, M. CHIARA · 2019 to 2023
$1.7M
NIH HHS R01NS109149NINDS NIH HHS R01 NS109149Robert Wood Johnson Foundation 74260
6 · The paper itself

Abstract

ATPase, class 1, type 8 A, member 2 (ATP8A2) is a P4-ATPase with a critical role in phospholipid translocation across the plasma membrane. Pathogenic variants in ATP8A2 are known to cause cerebellar ataxia, impaired intellectual development, and disequilibrium syndrome 4 (CAMRQ4) which is often associated with encephalopathy, global developmental delay, and severe motor deficits. Here, we present a family with two siblings born from a consanguineous, first-cousin union from Sudan presenting with global developmental delay, intellectual disability, spasticity, ataxia, nystagmus, and thin corpus callosum. Whole exome sequencing revealed a homozygous missense variant in the nucleotide binding domain of ATP8A2 (p.Leu538Pro) that results in near complete loss of protein expression. This is in line with other missense variants in the same domain leading to protein misfolding and loss of ATPase function. In addition, by performing diffusion-weighted imaging, we identified bilateral hyperintensities in the posterior limbs of the internal capsule suggesting possible microstructural changes in axon tracts that had not been appreciated before and could contribute to the sensorimotor deficits in these individuals.

Indexed as

Adenosine TriphosphatasesIntellectual DisabilityMutation, MissensePedigreePhenotypeChildChild, PreschoolConsanguinityDevelopmental DisabilitiesExome SequencingFemaleHumansMalePhospholipid Transfer ProteinsAdenosine TriphosphatasesATP8A2 protein, humanPhospholipid Transfer ProteinsATP8A2ATPase (Min.5-Max. 8)CAMRQ4Neurodevelopmental disorderRare variants

Identifiers

PMID39066872
PMCPMC11534842

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.